The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard.
KIKUYA Spring THC20 CBD≤1% has been verified as meeting the minimum quality standard.
FLOWERMAN Pine X THC16 CBD≤1% has been verified as meeting the minimum quality standard.
FLOWERMAN OMGO THC30 CBD<1 has been verified as meeting the minimum quality standard.
Bloom EGF has been verified as meeting the minimum quality standard.
Calmana T15 has been verified as meeting the minimum quality standard.
More information on the products can be found on the Ministry of Health website.
